Clinical trials
Acute Kidney Disease clinical trials
Below are recruiting acute kidney disease clinical trials, each written for real people, not researchers. We’re tracking 320 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07142252RecruitingPhase 2
New drug for recently diagnosed type 1 diabetes
This trial tests a new medicine (rezpegaldesleukin) to see if it can help preserve the body's ability to make some insulin in people recently diagnosed with type 1 diabetes. It's for children and adults diagnosed within the past 100 days.
Aurora, ColoradoAges 8–45 - NCT07175051RecruitingPhase 2
Testing a kidney-protecting drug in sickle cell disease
This study tests whether empagliflozin, a medicine that protects the kidneys in people with diabetes, can also protect the kidneys in people with sickle cell disease. The goal is to see if it can reduce protein in the urine, which is a sign of kidney stress.
Chicago, IllinoisAges 18–60 - NCT07222722Recruiting
Brain oxygen monitoring for preterm babies and kidney health
This trial uses a special monitor to check oxygen levels in the brain of very premature babies. It aims to see if low oxygen affects kidney health.
New York, New YorkAges 6 months–7 months - NCT07223502RecruitingPhase 3
Comparing two treatments for high blood pressure and kidney disease
This trial tests if a new treatment combination (finerenone plus a water pill) works better than a standard fixed-dose combination for people with both high blood pressure and chronic kidney disease. It aims to find which option provides more clinical benefit.
Vienna, VirginiaAges 18 years+ - NCT07229040RecruitingPhase 2
Kidney protection during heated chemotherapy surgery for ovarian cancer
This trial tests two drugs (cilastatin and thiosulfate) to see which one better protects the kidneys during surgery that uses heated cisplatin chemotherapy directly in the abdomen. It is for women with advanced ovarian cancer whose disease is mostly in the belly.
Madrid, MadridAges 18–75 - NCT07237451Recruiting
Heart and kidney study of SGLT2 inhibitors
This study looks at whether a type of diabetes medicine called SGLT2 inhibitors (also known as flozins) can help protect the heart and kidneys in people with both heart failure with preserved pumping function and moderate chronic kidney disease, with or without diabetes.
IașiAges 18 years+ - NCT07294859Recruiting
Ultrasound to predict kidney function after kidney removal
This trial uses special ultrasound techniques to predict how well your remaining kidney will work after surgery to remove part or all of one kidney. It may help doctors understand your recovery and tailor follow-up care.
Nanjing, JiangsuAges 18 years+ - NCT07413315Recruiting
Kidney rehab program for dialysis patients after hospital stay
This study tests a special exercise and education program for people on daily hemodialysis (a type of kidney treatment) who have recently been in the hospital. The goal is to see if this program helps you recover and feel better.
BrusselsAges 18 years+ - NCT07418242Recruiting
New markers for kidney risk after heart surgery
This study looks at whether certain blood or urine markers can predict kidney problems in people having high-risk heart surgery. The goal is to find early warning signs so doctors can take steps to protect your kidneys.
Shanghai, Shanghai MunicipalityAges 18–90 - NCT07447791Recruiting
Comparing low vs standard dialysis in ICU patients
This trial compares a lower dose versus a standard dose of continuous kidney replacement therapy (CRRT) for critically ill patients with acute kidney injury (AKI — sudden kidney failure). It aims to see if lower doses are safe and effective.
London, Greater LondonAges 18 years+ - NCT07462780RecruitingPhase 1
Testing CMS-D017 in Healthy Volunteers
This trial tests a new investigational drug called CMS-D017 in healthy volunteers. Researchers will give single and multiple doses to see how the body processes it and if it's safe. You could help find an important new treatment.
BeijingAges 18–55 - NCT07481526Recruiting
Chronic kidney disease registry study
This study is collecting information from people with chronic kidney disease (CKD) to understand how the disease progresses over time. It does not test any new treatments, so you keep your usual care.
ShanghaiAges Any age - NCT07522008Recruiting
Testing a blood-cleaning add-on for dialysis symptom relief
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
Cagliari, ItalyAges 18 years+ - NCT07635160Recruiting
Kidney Blood Flow Monitoring During Minimally Invasive Abdominal Surgery
This research study tests two imaging methods—ultrasound and a special light-based scanner—to monitor how well your kidneys receive blood during minimally invasive abdominal surgery. The goal is to understand kidney function better during this type of operation.
IstanbulAges 18–80 - NCT07499856Enrolling by invitation
Exercise and mindfulness during dialysis
This trial tests whether combining exercise with mindfulness (a mental relaxation technique) during dialysis sessions can improve well-being. You watch videos that guide you through exercises and mindfulness while receiving treatment.
Valencia, ValenciaAges 18 years+ - NCT07442448Enrolling by invitationPhase 4
Study of Finerenone for heart and kidney health in diabetes
This trial tests a medication called Finerenone to see if it can improve heart structure and function in people with both diabetic kidney disease and heart failure. If you have type 2 diabetes, kidney problems, and heart failure with preserved pumping function, this study may explore a new treatment option for you.
TaipeiAges 18 years+ - NCT05279742Enrolling by invitationPhase 1/Phase 2
Study drug to boost a hormone system in HFpEF
This early-phase trial tests a treatment that aims to improve the “natriuretic peptide” hormone system in people with HFpEF (heart failure with preserved pumping strength). It may help reduce symptoms and improve heart and fluid pressure behavior, especially in certain related conditions like kidney disease.
Rochester, MinnesotaAges 18 years+ - NCT03541785Enrolling by invitation
Using NGAL to guide fluids and start kidney-filtering in children
This study tests whether measuring a urine protein called NGAL can help doctors choose the right fluid amount and decide when to start a kidney-filtering treatment called CRRT in critically ill children with kidney injury. If it works, it may help treat kidney problems sooner and more safely.
Cincinnati, OhioAges 3 months–25 years - NCT07098351Recruiting
A trial for a new itchy skin medicine for people on peritoneal dialysis
This trial tests if a medication called nalfurafine hydrochloride (taken as a tablet that melts in your mouth) can help reduce moderate to severe itching in people receiving peritoneal dialysis for chronic kidney disease.
Guangzhou, GuangdongAges 18–85 - NCT06707532Recruiting
Muscle relaxants for safer heart rhythm treatment
This study tests if giving muscle relaxants before a heart ablation procedure can protect muscles from damage. Ablation uses energy to fix irregular heartbeats, and muscle relaxants might make it safer.
Wroclaw, Lower Silesian VoivodeshipAges 18–90 - NCT06793774Recruiting
Using CT scans and AI to evaluate heart artery risk
This study uses a CT scan of your heart (CCTA) and advanced computer analysis to see how well it can predict heart risks compared to detailed inside-look tests (IVUS, OCT, NIRS). If you have chest pain and have had certain heart scans, this trial may help doctors understand your condition better.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06793787Recruiting
AI and advanced imaging to guide treatment of borderline heart blockages
This study uses advanced CT scans and a special camera (OCT) to look at borderline blockages in heart arteries more closely. It aims to see if artificial intelligence can help decide which blockages need a stent and which can be treated with medicine alone.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT06927739RecruitingPhase 2
Orticumab for heart artery inflammation after a heart attack
This trial tests a drug called orticumab to see if it can reduce inflammation in the arteries of the heart after a heart attack. It may help prevent future heart problems.
Los Angeles, CaliforniaAges 18 years+ - NCT07047456RecruitingPhase 3
Stem cell infusion timing and graft-versus-host disease risk in blood cancer patients
This trial looks at whether the time when stem cells are infused affects the chance of developing graft-versus-host disease (aGVHD) after a cord blood transplant. It may help find the best timing to improve outcomes for people with blood cancers.
Hefei, AnhuiAges Any age
Hear when a new Acute Kidney Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for acute kidney disease?
- Yes. Clin2 currently lists 320 recruiting acute kidney disease studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a acute kidney disease trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a acute kidney disease trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.